Mini Review
Accepted on 09 Mar 2026
Recalibrating Cell Fate: Targeting the Mitochondrial Signaling Hub with Natural Active Compounds to Inhibit Regulated Cell Death in Diabetic Kidney Disease
in Mitochondrial Research
Mini Review
Accepted on 09 Mar 2026
in Mitochondrial Research
Review
Accepted on 09 Mar 2026
in Nutrition and Food Science Technology
Review
Accepted on 09 Mar 2026
in Translational Pharmacology
Editorial
Accepted on 09 Mar 2026
in Animal Breeding and Genetics
Original Research
Accepted on 09 Mar 2026
in Sport, Leisure, Tourism, and Events
Original Research
Accepted on 09 Mar 2026
in Fire and Forests
Original Research
Accepted on 09 Mar 2026
in Solid and Structural Mechanics
Review
Accepted on 09 Mar 2026
in Cancer Cell Biology
Original Research
Accepted on 09 Mar 2026
in Clinical Infectious Diseases
Review
Accepted on 09 Mar 2026
in Obstetric and Pediatric Pharmacology
Original Research
Accepted on 09 Mar 2026
in Infectious Diseases: Epidemiology and Prevention
Original Research
Accepted on 09 Mar 2026
in Schizophrenia
Original Research
Accepted on 09 Mar 2026
in Inflammation Pharmacology
Review
Accepted on 09 Mar 2026
in Pharmacogenetics and Pharmacogenomics
Original Research
Accepted on 09 Mar 2026
in Landscape and Geological Processes
Original Research
Accepted on 09 Mar 2026
in Integrative and Regenerative Pharmacology